|
 Products
 With a focus on familiar, everyday health problems, Pharmalef Developments aims to develop and deliver products that meet the individual’s health care needs, developing a wide range of products.
In addition to its established range of highly effective and distinctive products Pharmalef Developments will introduce several new products in new fields, including Rheumatology, Immunology and Respiratory Diseases.
|
 |
 Corporate
News
 Pharmalef
Inc. is starting coloboration in development of new oral delivery platform
offers pharmaceutical companies the ability to extend the shelf life and
stability of medicinal compounds.
Moreover, oral delivery improves patient compliance, improves treatment, reduces
patient inconvenience, and reduces treatment costs.
Our partners have completed proof of concept and development of a proliposomal
formulation for the model drug, calcitonin, which is used in the treatment
of osteoporosis and thyroid cancer.
Clinical trials are expected to begin at a number of centers across the United
States, Canada and European Union.
|
 |
 |
